Galactorrhea may be clue to serious problems: Patients deserve a thorough workup

Postgraduate Medicine

Volumn 107, Issue 7, 2000, Pages 165-171

  Whitman Elia, Gail F ^a   Windham, Nancy Q ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BUTYROPHENONE DERIVATIVE; METHYLDOPA; METOCLOPRAMIDE; PHENOTHIAZINE DERIVATIVE; PROLACTIN; RESERPINE; SULPIRIDE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DRUG INDUCED DISEASE; ENDOCRINE FUNCTION TEST; FEMALE; GALACTORRHEA; HUMAN; HYPERPROLACTINEMIA; HYPOPHYSIS DISEASE; MENSTRUATION DISORDER; NUCLEAR MAGNETIC RESONANCE IMAGING; PROLACTIN RELEASE; VISUAL DISORDER;

EID: 0033919358     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.2000.06.1129     Document Type: Article

References (6)

1. Blackwell RE. Pathophysiology of the breast. In: Becker KL, ed. Principles and practice of endocrinology and metabolism. Philadelphia: Lippincott, 1990:876-7
2. Yazigi R, Quintero CH, Salameh WA. Prolactin disorders, Fertil Steril 1997;67(2): 215-25
3. Cunnah D, Besser M. Management of prolactinomas. Clin Endocrinol 1991;34: 231-5
4. Kaltsas GA, Mukherjee JJ, Plowman PN, et al. The role of cytotoxic chemotherapy in the management of aggressive and malignant pituitary tumors. J Clin Endocrinol Metab 1998;83(12):4233-8
5. Shimon I, Melmed S. Genetic basis of endocrine disease. J Clin Endocrinol Metab 1997;82(6):1675-81
6. Popovic V, Damjanovic S, Mici D, et al. Increased incidence of neoplasia in patients with pituitary adenomas. The pituitary Study group. Clin Endocrinol (Oxf) 1998;49:441-5